Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) Document date: 2020_3_23
ID: 9hknw4ws_3
Snippet: Lopinavir was reported to have antiviral activity against MERS-CoV in Vero cells (concentration causing a 50% reduction in replication (EC50) = 8 µM) [ 8 ] ......
Document: Lopinavir was reported to have antiviral activity against MERS-CoV in Vero cells (concentration causing a 50% reduction in replication (EC50) = 8 µM) [ 8 ] .
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date